News

Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...
Gali Janardhana Reddy moves Telangana High Court for bail and suspension of CBI court's 7-year conviction in illegal mining ...
CWSCCM combines cutting-edge biosensing techniques for continuous cortisol monitoring, paving the way for personalized ...